Attention to Infection Prevention in Medical Aesthetic Clinics

Tracey A Hotta

doi:10.1097/PSN.0000000000000215

Attention to Infection Prevention in Medical Aesthetic Clinics

Plast Surg Nurs. 2018 Jan/Mar;38(1):17-24. doi: 10.1097/PSN.0000000000000215.

Author

Tracey A Hotta¹

Affiliation

¹ Tracey A. Hotta, BScN, RN, CPSN, CANS, LNC, Owner of TH Medical Aesthetics and Director of THMA Consulting Inc, Thornhill, Ontario, Canada.

PMID: 29494408
DOI: 10.1097/PSN.0000000000000215

Abstract

The risk of infection is a concern for all medical aesthetic industry and all providers. Steps to reduce the risk and improve patient outcomes begin with vigilance to proper aseptic technique and being less concerned about the "beauty image" to attract new patients. This article is based on the guidelines outlined in Infection Prevention and Control for Clinical Office Practice by Public Health Ontario.

MeSH terms

Botulinum Toxins, Type A / therapeutic use
Dermal Fillers / therapeutic use
Esthetics / education*
Hand Hygiene / methods
Humans
Infection Control / methods
Infection Control / standards*
Neuromuscular Agents / therapeutic use
Ontario
Personal Protective Equipment
Polyesters / therapeutic use

Substances

Dermal Fillers
Neuromuscular Agents
Polyesters
poly(lactide)
Botulinum Toxins, Type A